"Temporary withdrawal of glibenclamide, also known as glyburide, led to restoration of islet cell function in mice that had become glucose intolerant during continuous treatment with the sulfonylurea, Maria Sara Remedi, Ph. D., and Colin G. Nichols, Ph. D., of Washington University here, reported online in"